- Home
- FLGC vs KAPA Comparison
FLGC vs KAPA Comparison
Compare FLGC & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- KAPA
- Stock Information
- Founded
- FLGC 2019
- KAPA 2013
- Country
- FLGC United States
- KAPA United States
- Employees
- FLGC N/A
- KAPA N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- KAPA
- Sector
- FLGC Health Care
- KAPA
- Exchange
- FLGC Nasdaq
- KAPA NYSE
- Market Cap
- FLGC 26.5M
- KAPA 21.3M
- IPO Year
- FLGC 2021
- KAPA 2024
- Fundamental
- Price
- FLGC $1.31
- KAPA $1.48
- Analyst Decision
- FLGC Strong Buy
- KAPA Strong Buy
- Analyst Count
- FLGC 3
- KAPA 1
- Target Price
- FLGC $6.50
- KAPA $9.00
- AVG Volume (30 Days)
- FLGC 515.7K
- KAPA 720.9K
- Earning Date
- FLGC 11-13-2024
- KAPA 11-14-2024
- Dividend Yield
- FLGC N/A
- KAPA N/A
- EPS Growth
- FLGC N/A
- KAPA N/A
- EPS
- FLGC N/A
- KAPA N/A
- Revenue
- FLGC $64,154,000.00
- KAPA N/A
- Revenue This Year
- FLGC N/A
- KAPA N/A
- Revenue Next Year
- FLGC $19.90
- KAPA N/A
- P/E Ratio
- FLGC N/A
- KAPA N/A
- Revenue Growth
- FLGC N/A
- KAPA N/A
- 52 Week Low
- FLGC $0.75
- KAPA $1.22
- 52 Week High
- FLGC $2.93
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- FLGC 47.10
- KAPA N/A
- Support Level
- FLGC $1.19
- KAPA N/A
- Resistance Level
- FLGC $1.38
- KAPA N/A
- Average True Range (ATR)
- FLGC 0.14
- KAPA 0.00
- MACD
- FLGC -0.01
- KAPA 0.00
- Stochastic Oscillator
- FLGC 39.05
- KAPA 0.00
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.